查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828065

2025年免疫組織化學（IHC）全球市場報告

Immunohistochemistry (IHC) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，免疫組織化學 (IHC) 市場呈現強勁成長勢頭，市場規模從 2024 年的 25.8 億美元成長至 2025 年的 27.6 億美元，複合年成長率達 7.2%。這段時期的成長得益於臨床應用、產業標準化、癌症研究的不斷擴展、實驗室自動化以及臨床診斷技術的進步。

預計未來幾年免疫組織化學 (IHC) 市場將快速成長，到 2029 年將達到 40.7 億美元，複合年成長率為 10.2%。預測期內的成長主要源自於新參與企業的市場、藥物開發、生物醫學研究整合、診斷應用、自動化數位化。預測期內的主要趨勢包括多重 IHC 技術、數位病理學整合、抗體特異性的提高、自動化和標準化以及在生物標記發現中的應用。

免疫組織化學 (IHC) 是一種利用抗體-抗原交互作用來識別組織切片中特定蛋白質或抗原的診斷技術。這種相互作用可以透過使用酶基材的顯色檢測或使用螢光染料的螢光檢測來可視化。

免疫組織化學 (IHC) 相關的關鍵產品包括抗體、儀器、試劑和套件。抗體是由免疫系統產生的蛋白質，用於中和有害抗原。在 IHC 領域，抗體用於檢測蛋白質或抗原的特定位置，以用於診斷目的。 IHC 的應用涵蓋診斷、藥物檢測和其他相關領域，最終用戶包括醫院、診斷實驗室和研究機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供免疫組織化學 (IHC) 市場統計數據，例如全球市場規模、區域佔有率、免疫組織化學 (IHC) 市場佔有率競爭對手、詳細的免疫組織化學 (IHC) 細分市場、市場趨勢和機遇，以及您在免疫組織中取得成功所需的數據。本免疫組織化學 (IHC) 市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為10.2%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會透過供應鏈中斷直接影響美國，例如來自比利時和新加坡等主要地區的自動染色平台和抗原捕獲緩衝液，這可能導致癌症生物標記分析的延遲和組織病理學檢測成本的增加。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

由於慢性病的盛行率不斷上升，免疫組織化學 (IHC) 市場預計將持續成長。慢性病是指通常可控制但無法治癒的長期疾病，包括癌症和心血管疾病等。免疫組織化學具有特異性強、檢測特異性抗原的敏感度高以及快速出結果等優勢，使其成為診斷這些疾病的關鍵。美國疾病管制與預防中心報告稱，2022 年美國將有約 3,730 萬人患糖尿病，佔總人口的 11.3%，這凸顯了免疫組織化學在應對日益加重的慢性病負擔方面發揮的作用。

免疫組織化學 (IHC) 市場的成長進一步受到個人化醫療需求的推動，個人化醫療是指根據每位患者獨特的基因、環境和生活方式特徵，量身定做醫療決策和干涉措施。免疫組織化學在其中發揮關鍵作用，它能夠檢測對腫瘤準確分類和診斷至關重要的特異性蛋白質標記物。個人化醫療聯盟預測，未來將有超過 75,000 種基因檢測產品和 300 多種個人化藥物可用於治療各種疾病，凸顯了免疫組織化學在個人化醫療發展中的關鍵作用。

免疫組織化學 (IHC) 市場涵蓋一抗、玻片染色系統、組織微陣列、組織處理系統、玻片掃描儀、二抗、組織染色劑、封閉血清及試劑、呈色受質、固定劑和穩定劑的銷售。該市場的價值為「工廠門口」價值，即商品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 整體免疫組織化學 (IHC)：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球免疫組織化學（IHC）市場：成長率分析
  • 全球免疫組織化學 (IHC) 市場表現：規模與成長，2019-2024 年
  • 全球免疫組織化學 (IHC) 市場預測：規模與成長，2024-2029 年，2034 年
  • 全球免疫組織化學（IHC）：總目標市場（TAM）

第6章 市場細分

  • 全球免疫組織化學 (IHC) 市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 抗體
  • 裝置
  • 試劑
  • 套件
  • 全球免疫組織化學 (IHC) 市場的應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷
  • 藥物檢測
  • 其他
  • 全球免疫組織化學 (IHC) 市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診斷實驗室
  • 研究所
  • 其他
  • 全球免疫組織化學 (IHC) 市場：抗體細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 一抗
  • 二抗
  • 結合抗體
  • 全球免疫組織化學 (IHC) 市場：儀器細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • IHC染色系統
  • 組織處理裝置
  • 幻燈片掃描儀
  • 顯微鏡
  • 全球免疫組織化學 (IHC) 市場：試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 檢測試劑
  • 阻斷試劑
  • 鑲嵌劑
  • 全球免疫組織化學 (IHC) 市場：套件細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 即用型 IHC套件
  • 多重 IHC套件
  • 特殊套件

第7章 區域和國家分析

  • 全球免疫組織化學 (IHC) 市場各地區、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 全球免疫組織化學 (IHC) 市場（按國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 免疫組織化學（IHC）市場：競爭格局
  • 免疫組織化學（IHC）市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche AG
    • The Merck Group
    • Danaher Corporation
    • PerkinElmer Inc.

第31章：其他領先和創新企業

  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Bio SB Inc.
  • Agilent Technologies Inc.
  • Abcam plc
  • Becton Dickinson and Company
  • Takara Bio Inc.
  • Biocare Medical LLC
  • Bio-Genex Laboratories
  • Diagnostic BioSystems Inc.
  • BioVision Inc.
  • PHC Holdings Corporation
  • Abbott Laboratories
  • Leica Biosystems
  • Vector Laboratories

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年免疫組織化學 (IHC) 市場：提供新機會的國家
  • 2029 年免疫組織化學 (IHC) 市場：細分領域帶來新機會
  • 免疫組織化學 (IHC) 市場，2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23460u

Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.

The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The immunohistochemistry (IHC) market research report is one of a series of new reports from The Business Research Company that provides immunohistochemistry (IHC) market statistics, including immunohistochemistry (IHC) industry global market size, regional shares, competitors with a immunohistochemistry (IHC) market share, detailed immunohistochemistry (IHC) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (IHC) industry. This immunohistochemistry (IHC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.58 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements.

The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization. Major trends in the forecast period include multiplex IHC techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery.

The forecast of 10.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for automated staining platforms and antigen retrieval buffers, sourced from key regions such as Belgium and Singapore, which could lead to slower cancer biomarker analysis and increased histopathology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The immunohistochemistry (IHC) market is anticipated to witness growth due to the increasing prevalence of chronic diseases. Chronic diseases, lasting for extended periods and typically manageable but not curable, include conditions such as cancer and cardiovascular disorders. Immunohistochemistry is crucial in diagnosing these diseases, offering advantages such as specificity, sensitivity to detect specific antigens, and rapid results. In 2022, the Centers for Disease Control and Prevention reported that approximately 37.3 million people in the United States, accounting for 11.3% of the population, have diabetes, emphasizing the role of immunohistochemistry in addressing the rising burden of chronic diseases.

The growth of the immunohistochemistry (IHC) market is further driven by the increasing demand for personalized medicines. Personalized medicine tailors medical decisions and interventions based on individual patients' unique genetic, environmental, and lifestyle characteristics. Immunohistochemistry plays a significant role in this context, detecting specific protein markers crucial for accurate tumor classification and diagnosis. The Personalized Medicine Coalition projected that over 75,000 genetic testing products and 300 personalized medicines will be available for various diseases, reinforcing the pivotal role of immunohistochemistry in advancing personalized medicine.

Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.

Leading companies in the immunohistochemistry (IHC) market are prioritizing technological advancements, such as automated staining systems, to boost diagnostic accuracy and efficiency for pathologists, ultimately improving patient outcomes. The Tissue-Tek Genie represents an innovative, fully automated staining system for immunohistochemistry (IHC) and in situ hybridization (ISH), designed to deliver rapid, high-quality, and standardized results to enhance diagnostic precision in histopathology. For instance, in September 2022, Sakura Finetek, a US-based medical equipment company, launched its latest solution, Tissue-Tek Genie, an advanced staining system focused on providing optimal scoring antibodies for the best possible results for pathologists and their patients. The Tissue-Tek Genie Advanced Staining System is the first fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridization (ISH).

In November 2022, Leica Biosystems, a Germany-based medical devices firm, acquired Cell IDx, Inc. for an undisclosed sum. This acquisition aims to enhance Leica Biosystems' multiplex immunohistochemistry (IHC) capabilities and improve cancer diagnostics by integrating its UltraPlex technology for advanced biomarker detection and tissue-based diagnostics. Cell IDx is a US-based biotechnology company specializing in multiplexed tissue profiling.

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohistochemistry (IHC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohistochemistry (ihc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohistochemistry (ihc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Antibodies; Equipment; Reagents; Kits
  • 2) By Applications: Diagnostics; Drug Testing; Other Applications
  • 3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies
  • 2) By Equipment: IHC Staining Systems; Tissue Processors; Slide Scanners; Microscopes
  • 3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
  • 4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; The Merck Group; Danaher Corporation; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB Inc.; Agilent Technologies Inc.; Abcam plc; Becton Dickinson and Company; Takara Bio Inc.; Biocare Medical LLC; Bio-Genex Laboratories; Diagnostic BioSystems Inc.; BioVision Inc.; PHC Holdings Corporation; Abbott Laboratories; Leica Biosystems; Vector Laboratories; Indivumed GmbH; Qritive; Ionpath Inc.; Reveal Biosciences; Akrivis Technologies Private Limited; LifeSpan BioSciences Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; GenScript Biotech; Histologix Ltd.; NeoGenomics Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohistochemistry (IHC) Market Characteristics

3. Immunohistochemistry (IHC) Market Trends And Strategies

4. Immunohistochemistry (IHC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunohistochemistry (IHC) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunohistochemistry (IHC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunohistochemistry (IHC) Market Growth Rate Analysis
  • 5.4. Global Immunohistochemistry (IHC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunohistochemistry (IHC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunohistochemistry (IHC) Total Addressable Market (TAM)

6. Immunohistochemistry (IHC) Market Segmentation

  • 6.1. Global Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibodies
  • Equipment
  • Reagents
  • Kits
  • 6.2. Global Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Testing
  • Other Applications
  • 6.3. Global Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Research Institutes
  • Other End-Users
  • 6.4. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Antibodies
  • Secondary Antibodies
  • Conjugated Antibodies
  • 6.5. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • IHC Staining Systems
  • Tissue Processors
  • Slide Scanners
  • Microscopes
  • 6.6. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Reagents
  • Blocking Reagents
  • Mounting Media
  • Microscopes
  • 6.7. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-prepared IHC Kits
  • Multiplex IHC Kits
  • Specialty Kits

7. Immunohistochemistry (IHC) Market Regional And Country Analysis

  • 7.1. Global Immunohistochemistry (IHC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunohistochemistry (IHC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohistochemistry (IHC) Market

  • 8.1. Asia-Pacific Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohistochemistry (IHC) Market

  • 9.1. China Immunohistochemistry (IHC) Market Overview
  • 9.2. China Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohistochemistry (IHC) Market

  • 10.1. India Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohistochemistry (IHC) Market

  • 11.1. Japan Immunohistochemistry (IHC) Market Overview
  • 11.2. Japan Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohistochemistry (IHC) Market

  • 12.1. Australia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohistochemistry (IHC) Market

  • 13.1. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohistochemistry (IHC) Market

  • 14.1. South Korea Immunohistochemistry (IHC) Market Overview
  • 14.2. South Korea Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohistochemistry (IHC) Market

  • 15.1. Western Europe Immunohistochemistry (IHC) Market Overview
  • 15.2. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohistochemistry (IHC) Market

  • 16.1. UK Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohistochemistry (IHC) Market

  • 17.1. Germany Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohistochemistry (IHC) Market

  • 18.1. France Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohistochemistry (IHC) Market

  • 19.1. Italy Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohistochemistry (IHC) Market

  • 20.1. Spain Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohistochemistry (IHC) Market

  • 21.1. Eastern Europe Immunohistochemistry (IHC) Market Overview
  • 21.2. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohistochemistry (IHC) Market

  • 22.1. Russia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohistochemistry (IHC) Market

  • 23.1. North America Immunohistochemistry (IHC) Market Overview
  • 23.2. North America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohistochemistry (IHC) Market

  • 24.1. USA Immunohistochemistry (IHC) Market Overview
  • 24.2. USA Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohistochemistry (IHC) Market

  • 25.1. Canada Immunohistochemistry (IHC) Market Overview
  • 25.2. Canada Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohistochemistry (IHC) Market

  • 26.1. South America Immunohistochemistry (IHC) Market Overview
  • 26.2. South America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohistochemistry (IHC) Market

  • 27.1. Brazil Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohistochemistry (IHC) Market

  • 28.1. Middle East Immunohistochemistry (IHC) Market Overview
  • 28.2. Middle East Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohistochemistry (IHC) Market

  • 29.1. Africa Immunohistochemistry (IHC) Market Overview
  • 29.2. Africa Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohistochemistry (IHC) Market Competitive Landscape And Company Profiles

  • 30.1. Immunohistochemistry (IHC) Market Competitive Landscape
  • 30.2. Immunohistochemistry (IHC) Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohistochemistry (IHC) Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Cell Signaling Technology Inc.
  • 31.3. Bio SB Inc.
  • 31.4. Agilent Technologies Inc.
  • 31.5. Abcam plc
  • 31.6. Becton Dickinson and Company
  • 31.7. Takara Bio Inc.
  • 31.8. Biocare Medical LLC
  • 31.9. Bio-Genex Laboratories
  • 31.10. Diagnostic BioSystems Inc.
  • 31.11. BioVision Inc.
  • 31.12. PHC Holdings Corporation
  • 31.13. Abbott Laboratories
  • 31.14. Leica Biosystems
  • 31.15. Vector Laboratories

32. Global Immunohistochemistry (IHC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

34. Recent Developments In The Immunohistochemistry (IHC) Market

35. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies

  • 35.1 Immunohistochemistry (IHC) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunohistochemistry (IHC) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunohistochemistry (IHC) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer